<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04171024</url>
  </required_header>
  <id_info>
    <org_study_id>2019-A00782-55</org_study_id>
    <nct_id>NCT04171024</nct_id>
  </id_info>
  <brief_title>Transcutaneous Diaphragm Electrical Stimulation in Critically Ill Patients</brief_title>
  <acronym>TESLA</acronym>
  <official_title>Transcutaneous Diaphragm Electrical StimuLAtion in Critically Ill Patients to Prevent Diaphragm Dysfunction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Groupe Hospitalier du Havre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Groupe Hospitalier du Havre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the effect of a transcutaneous electrical stimulation in critically ill
      patients compared to a sham electrical stimulation to decrease the incidence of diaphragm
      dysfunction before mechanical ventilation weaning.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 10, 2019</start_date>
  <completion_date type="Anticipated">January 7, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2022</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diaphragm Thickening fraction</measure>
    <time_frame>Once, At the start of the spontaneous breathing trial</time_frame>
    <description>Diaphragm ultrasound was conducted using a 4-12-MHz linear array transducer. Diaphragm thickness was measured at end-expiration (Tdi,ee) and end inspiration (Tdi,ei), and thickening fraction (TFdi) was calculated offline as (Tdi,ei-Tdi,ee)/Tdi,ee.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diaphragm atrophy</measure>
    <time_frame>Once a day under mechanical ventilation, throughout the study</time_frame>
    <description>Diaphragm thickeness is measured each day of the study until mechanical ventilation weaning</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inspiratory strength</measure>
    <time_frame>Once, At the start of the spontaneous breathing trial</time_frame>
    <description>Maximal inspiratory pressure is measured via an electrical manometer with unidirectional valve</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cough strength</measure>
    <time_frame>Once, At the start of the spontaneous breathing trial</time_frame>
    <description>Peak expiratory cough flow is measured with the ventilator</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients successfully liberated from the ventilator</measure>
    <time_frame>After 3 days of spontaneous breathing</time_frame>
    <description>Extubation failure is reported when a patient present a respiratory distress and need an tracheal intubation in the 48 hours past extubation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">66</enrollment>
  <condition>Critical Illness</condition>
  <condition>Mechanical Ventilation</condition>
  <condition>Intensive Care Unit</condition>
  <arm_group>
    <arm_group_label>Sham Group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Two channels with two electrodes each were placed above and below the right and left sides of the xiphoid process within the seventh and eighth anterior intercostal space. In addition, two channels with two electrodes each were placed on the right and left midaxillary line of the seventh and eighth anterior intercostal space.
Transcutaneous electrical stimulation settings: Frequency (2 hertz); wave length (300 µs);</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Transcutaneous diaphragm electrical stimulation group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Two channels with two electrodes each were placed above and below the right and left sides of the xiphoid process within the seventh and eighth anterior intercostal space. In addition, two channels with two electrodes each were placed on the right and left midaxillary line of the seventh and eighth anterior intercostal space.
Transcutaneous electrical stimulation settings: Frequency (35 hertz); wave length (300 µs); Intensity to achieve a visual contraction</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham electrical stimulation</intervention_name>
    <description>A non invasive sham diaphragm electrical stimulation using transcutaneous thoracic probes</description>
    <arm_group_label>Sham Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcutaneous diaphragm electrical stimulation</intervention_name>
    <description>A non invasive diaphragm electrical stimulation using transcutaneous thoracic probes</description>
    <arm_group_label>Transcutaneous diaphragm electrical stimulation group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients intubated and ventilated for at least 24 h

          -  Patients who were expected to have at least 48h after inclusion

        Exclusion Criteria:

          -  Patient with pacemaker

          -  Patient under neuro muscular blocker

          -  Patient post thoracic or abdominal surgery

          -  Patient with BMI more than 35 kg/m²

          -  Patient with degenerative neurological pathology

          -  Patient with cutaneous lesion may be interfered with probes

          -  Patient with chronic loss of autonomy

          -  Patient hospitalized more than 72 hours before ICU admission

          -  Patient with severe chronic obstructive pulmonary disease (FEV1 &lt; 30%)

          -  Patient with decision to withhold life-sustaining treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Clement Medrinal, PhD</last_name>
    <phone>+33630039745</phone>
    <email>medrinal.clement.mk@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Clement Medrinal, PhD</last_name>
    <phone>+33630039745</phone>
    <email>clement.medrinal@ch-havre.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medrinal</name>
      <address>
        <city>Le Havre</city>
        <zip>76600</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clement Medrinal</last_name>
      <phone>+33630039745</phone>
      <email>medrinal.clement.mk@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Clement Medrinal</last_name>
      <phone>+33630039745</phone>
      <email>clement.medrinal@ch-havre.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Clement Medrinal, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Guillaume Prieur, Msc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yann Combret, Msc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>November 8, 2019</study_first_submitted>
  <study_first_submitted_qc>November 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 20, 2019</study_first_posted>
  <last_update_submitted>January 3, 2020</last_update_submitted>
  <last_update_submitted_qc>January 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Groupe Hospitalier du Havre</investigator_affiliation>
    <investigator_full_name>Clément MEDRINAL</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Diaphragm dysfunction</keyword>
  <keyword>Transcutaneous Electrical Stimulation</keyword>
  <keyword>Intensive care unit</keyword>
  <keyword>Mechanical ventilation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

